Erik Eliasson

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2025

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (6)

Stefania Koutsilieri

Karolinska Institutet

SWEDEN

View details

Sara Margolin

Karolinska Institutet

SWEDEN

View details

Volker Lauschke

Professor

Karolinska Institutet

SWEDEN

View details

Yitian Zhou

Karolinska Institutet

SWEDEN

View details

Felix Grassmann

Professor of Epidemiology

Health and Medical University

GERMANY

View details

Espen Molden

NORWAY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Erik Eliasson

Research Interests

Explore related searches

Contact this professor

Articles (11)

CYP2D6 genotype and outcome in tamoxifen treated early breast cancer

Adherence to endocrine therapy in early breast cancer in relation to Cytochrome P450 2D6 genotype: a comparison between pharmacy dispensation data and medical records

Global distribution of functionally important CYP2C9 alleles and their inferred metabolic consequences

Reproducible Quantification of Unbound Fractions of Four Beta-Lactam Antibiotics: Ultrafiltration Versus Microdialysis of Spiked Healthy Donor Plasma

A paradigm shift in pharmacogenomics: From candidate polymorphisms to comprehensive sequencing

Low attainment to PK/PD-targets for β-lactams in a multi-center study on the first 72 h of treatment in ICU patients

Bleeding and thromboembolism due to drug-drug interactions with non-vitamin K antagonist oral anticoagulants—a Swedish, register-based cohort study in atrial fibrillation outpatients

CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trial

Impact of systemic adjuvant therapy and CYP2D6 activity on mammographic density in a cohort of tamoxifen-treated breast cancer patients

Impairment of endoxifen formation in tamoxifen-treated premenopausal breast cancer patients carrying reduced-function CYP2D6 alleles

Poor Correlation between Meropenem and Piperacillin Plasma Concentrations and Delivered Dose of Continuous Renal Replacement Therapy

Collaborators (6)

Stefania Koutsilieri

Sara Margolin

Volker Lauschke

Yitian Zhou

Felix Grassmann

Espen Molden

Make your next move.